Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Biogen lays out $5.6B to acquire Apellis
Biogen is bulking up in immunology—and paving the way for its nephrology future—with an M&A play that adds two ongoing launches to its marketed lineup.
Fraiser Kansteiner
Mar 31, 2026 10:32am
API supplier BASF raises prices, citing rising energy costs
Mar 31, 2026 11:00am
Smarter HCP engagement starts earlier
Brought to you by
Phreesia Network Solutions
Insulet hires Stryker vet, reinstating commercial chief role
Mar 31, 2026 9:45am
BMS, Novartis, Gilead, Iovance dinged in CBER untitled letters
Mar 30, 2026 10:00pm
Lilly 'optimistic' on UK deal that would see higher NHS prices: FT
Mar 30, 2026 3:41pm
More News
United's Tyvaso backs up case for IPF expansion with ph. 3 win
Mar 30, 2026 3:06pm
Regulatory tracker: GSK's Exdensur wins asthma nod in China
Mar 30, 2026 2:00pm
Idorsia eyes pediatric insomnia market with ph. 2 win
Mar 30, 2026 11:25am
Takeda to cut 634 US jobs in massive $1.3B restructuring
Mar 30, 2026 10:29am
